FDA to expedite development of two Sanofi rare disease drugsThe FDA has agreed to expedite development of two rare disease drugs from Sanofi. The most significant of Share XFDA to expedite development of two Sanofi rare disease drugshttps://pharmaphorum.com/news/fda-to-expedite-development-of-two-sanofi-rare-disease/
